JP2020510617A5 - - Google Patents

Download PDF

Info

Publication number
JP2020510617A5
JP2020510617A5 JP2019529473A JP2019529473A JP2020510617A5 JP 2020510617 A5 JP2020510617 A5 JP 2020510617A5 JP 2019529473 A JP2019529473 A JP 2019529473A JP 2019529473 A JP2019529473 A JP 2019529473A JP 2020510617 A5 JP2020510617 A5 JP 2020510617A5
Authority
JP
Japan
Prior art keywords
benzyl
pyrazine
phenyl
oxo
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019529473A
Other languages
English (en)
Japanese (ja)
Other versions
JP7139330B2 (ja
JP2020510617A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/064229 external-priority patent/WO2018102693A1/en
Publication of JP2020510617A publication Critical patent/JP2020510617A/ja
Publication of JP2020510617A5 publication Critical patent/JP2020510617A5/ja
Application granted granted Critical
Publication of JP7139330B2 publication Critical patent/JP7139330B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019529473A 2016-12-01 2017-12-01 細胞不透過性セレンテラジンアナログ Active JP7139330B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662428997P 2016-12-01 2016-12-01
US62/428,997 2016-12-01
US201762477512P 2017-03-28 2017-03-28
US62/477,512 2017-03-28
PCT/US2017/064229 WO2018102693A1 (en) 2016-12-01 2017-12-01 Cell impermeable coelenterazine analogues

Publications (3)

Publication Number Publication Date
JP2020510617A JP2020510617A (ja) 2020-04-09
JP2020510617A5 true JP2020510617A5 (https=) 2021-01-21
JP7139330B2 JP7139330B2 (ja) 2022-09-20

Family

ID=60972321

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019529473A Active JP7139330B2 (ja) 2016-12-01 2017-12-01 細胞不透過性セレンテラジンアナログ

Country Status (5)

Country Link
US (2) US10577370B2 (https=)
EP (2) EP3548492B1 (https=)
JP (1) JP7139330B2 (https=)
DK (1) DK3548492T5 (https=)
WO (1) WO2018102693A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3548492B1 (en) * 2016-12-01 2023-07-05 Promega Corporation Cell impermeable coelenterazine analogues
JP7036343B2 (ja) * 2017-03-28 2022-03-15 国立大学法人電気通信大学 新規セレンテラジン誘導体
JP7419260B2 (ja) * 2018-05-01 2024-01-22 プロメガ コーポレイション NanoLuc自殺基質としてのセレンテラジン化合物
WO2020041579A1 (en) * 2018-08-23 2020-02-27 Promega Corporation Coelenterazine analogues
CA3114424A1 (en) 2018-10-03 2020-04-09 Promega Corporation Compositions and methods for stabilizing coelenterazine and analogs and derivatives thereof
CN111116594B (zh) * 2019-12-03 2021-05-28 山东大学 一种C-6位改造NanoLuc类型类似物及其制备方法与应用
KR102940072B1 (ko) * 2022-01-10 2026-03-17 주식회사 엘지화학 환상 술폰산에스테르 유도체 화합물의 제조방법
CN116082185B (zh) * 2023-04-06 2023-07-21 佛山职业技术学院 虫酰肼类半抗原、抗原、抗体、检测装置及其制备与应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7268229B2 (en) 2001-11-02 2007-09-11 Promega Corporation Compounds to co-localize luminophores with luminescent proteins
US8883486B2 (en) 2004-05-04 2014-11-11 Universite De Montreal Arrestin biosensor
WO2008118445A1 (en) 2007-03-26 2008-10-02 Promega Corporation Methods to quench light from optical reactions
ES2795287T3 (es) 2009-05-01 2020-11-23 Promega Corp Luciferasas de Oplophorus sintéticas con mayor emisión de luz
SG10202103336SA (en) 2010-11-02 2021-04-29 Promega Corp Novel coelenterazine substrates and methods of use
CN103180324A (zh) 2010-11-02 2013-06-26 普罗美加公司 腔肠素衍生物及其使用方法
JP6067019B2 (ja) 2011-09-02 2017-01-25 プロメガ コーポレイションPromega Corporation 代謝的に活性な細胞の酸化還元状態を評価するための化合物及び方法、ならびにnad(p)/nad(p)hを測定するための方法
WO2013078244A1 (en) 2011-11-21 2013-05-30 Promega Corporation Carboxy x rhodamine analogs
CN104395306B (zh) * 2012-03-02 2019-04-23 皮尔斯生物科技有限公司 作为生物分子的标记染料的吲哚衍生物
EP3099691B1 (en) 2014-01-29 2019-11-20 Promega Corporation Pro-substrates for live cell applications
US9790537B2 (en) 2014-01-29 2017-10-17 Promega Corporation Quinone-masked probes as labeling reagents for cell uptake measurements
WO2016210294A1 (en) 2015-06-25 2016-12-29 Promega Corporation Thienopyrrole compounds and uses thereof as inhibitors of oplophorus-derived luciferases
JP7092677B2 (ja) 2016-02-15 2022-06-28 プロメガ コーポレイション セレンテラジン類似体
CN105968114B (zh) * 2016-05-27 2018-11-09 山东大学 一种腔肠素类似物及其制备方法与应用
JP7212612B2 (ja) * 2016-07-28 2023-01-25 プロメガ コーポレイション セレンテラジン類縁体
JP7200102B2 (ja) * 2016-11-01 2023-01-06 プロメガ コーポレイション エネルギー受容体に係留されたセレンテラジン類縁体
EP3548492B1 (en) * 2016-12-01 2023-07-05 Promega Corporation Cell impermeable coelenterazine analogues

Similar Documents

Publication Publication Date Title
JP2020510617A5 (https=)
JP2020503274A5 (https=)
RU2436780C2 (ru) Производные 5-фенилтиазола и их применение в качестве ингибиторов рi3 киназы
RU2010101302A (ru) Замещенные оксазолидиноны и их применение
ME02906B (me) Derivati pirazolopirolidina i njihova upotreba u liječenju bolesti
RU2009123525A (ru) ПРОИЗВОДНЫЕ 5-СУЛЬФАНИЛМЕТИЛ[1,2,4}ТРИАЗОЛ[1,5-а]ПИРИМИДИН-7-ОЛА В КАЧЕСТВЕ АНТАГОНИСТОВ CXCR2
RU2008152180A (ru) ПРОИЗВОДНЫЕ ПИРРОЛА, МОДУЛИРУЮЩИЕ АКТИВНОСТЬ CRTh2 РЕЦЕПТОРА
JP2016529235A5 (https=)
JP2007519694A5 (https=)
RU98104091A (ru) Галоидные производные бензимидазола и их применение в качестве микробицидов
JP2004175807A5 (https=)
EP1773341A1 (en) Piperazine derivatives for the treatment of female sexual disorders
MX9804108A (es) Derivados de quinolina-4-carboxamida, su preparacion y uso como antagonistas receptores de neuroquinina 3 (nk-3)- y neuroquinina 2 (kn-2).
JP2011506438A5 (https=)
JP2002529532A5 (https=)
JP2013544893A5 (https=)
RU2006142738A (ru) Антагонисты рецептора crth2
JP2006528597A5 (https=)
JP2019524763A5 (https=)
JP2019504050A5 (https=)
US11344532B2 (en) Topically administrable formulation for the control and prevention of animal parasites
JP2016535769A5 (https=)
DK1202957T3 (da) Aminobenzofenoner som inhibitorer for IL-1beta og TNF-alfa
RU2017118369A (ru) Соединения для применения в дегельминтизации
RU2403253C2 (ru) Пуриновые производные для применения в качестве агонистов аденозинового рецептора а-2а